JPRN-UMIN000028502已完成未知
Study of the symptom improvement effect of gastric acid secretion inhibitors for refluxe esophagitis patients -Randomized controlled comparative test of vonoprazan and esomeprazole- - Study of the symptom improvement effect of gastric acid secretion inhibitors for refluxe esophagitis patients
ational Hospital Organization National Kochi Hospital0 个研究点目标入组 30 人开始时间: 2017年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a history of gastrointestinal resection or vagotomy. 2.Patients with confirmed or susupected malignant disease. 3.Pregnancy or lactation. 4.Past history of allergy for the drugs used in this therapy. 5.Ptients with sever liver dysfunction,sever renal dysfunction,sever hert dysfunction. 6.Ptients who are disqualifid for the study by physicians.
研究者
相似试验
已完成
不适用
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients with type 2 diabetes mellitus -a randomized comparative study of vonoprazan vs esomeprazoleReflux esophagitis with type 2 diabetes mellitusJPRN-UMIN000026407Hachinohe City Hospital Department of Endocrinology and Diabetes40
已完成
不适用
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients -a randomized comparative study of vonoprazan vs esomeprazoleReflux esophagitisJPRN-UMIN000022166Department of Gastroenterology, Sapporo-kosei General Hospital40
已完成
不适用
Verification of gastric symptom improvement effect in continuous intake of the lactic acid bacteriaJPRN-UMIN000042422APO PLUS STATION CO., LTD.180
已完成
不适用
A Study of the Improvement of Symptoms in GERD Patients by Practical Use of Esomeprazole 20mgJPRN-UMIN000018456Ishihara Gastroenterology clini20
招募中
不适用
Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis.Reflex esophagitisJPRN-UMIN000028962Ikoma Gastorenteroproctorogy Clinic40